Jim Cramer Reveals Why Drug Stocks Don't Go On Sale Anymore
Cramer's outlook on drug stocks.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said drug stocks don't go on sale anymore because interest rates are so low.
Bristol Myers Squibb (BMY) - Get Report shares moved lower on Wednesday amid lackluster results from a kidney cancer drug test.
Watch all of Jim Cramer's latest videos, right here:
- Jim Cramer: Agilent Technology Has Been One of My Favorites
- Jim Cramer's Retail Lighting Round: TJX Companies, Coach, Urban Outfitters and Dick's Sporting Goods
- Alibaba Trades Erratically on Earnings Day, Jim Cramer Says
- Target Under Promised and Over Delivered, Jim Cramer Says
- Apple's $1 Billion Programming Investment Takes Aim at Netflix, Jim Cramer Says
